Abstract:Background: The identification of compound-protein interactions (CPIs) is crucial for drug discovery and understanding mechanisms of action. Accurate CPI prediction can elucidate drug-target-disease interactions, aiding in the discovery of candidate compounds and effective synergistic drugs, particularly from traditional Chinese medicine (TCM). Existing in silico methods face challenges in prediction accuracy and generalization due to compound and target diversity and the lack of largescale interaction datasets and negative datasets for model learning. Methods: To address these issues, we developed a computational model for CPI prediction by integrating the constructed large-scale bioactivity benchmark dataset with a deep learning (DL) algorithm. To verify the accuracy of our CPI model, we applied it to predict the targets of compounds in TCM. An herb pair of Astragalus membranaceus and Hedyotis diffusaas was used as a model, and the active compounds in this herb pair were collected from various public databases and the literature. The complete targets of these active compounds were predicted by the CPI model, resulting in an expanded target dataset. This dataset was next used for the prediction of synergistic antitumor compound combinations. The predicted multi-compound combinations were subsequently examined through in vitro cellular experiments. Results: Our CPI model demonstrated superior performance over other machine learning models, achieving an area under the Receiver Operating Characteristic curve (AUROC) of 0.98, an area under the precision-recall curve (AUPR) of 0.98, and an accuracy (ACC) of 93.31% on the test set. The model's generalization capability and applicability were further confirmed using external databases. Utilizing this model, we predicted the targets of compounds in the herb pair of Astragalus membranaceus and Hedyotis diffusaas, yielding an expanded target dataset. Then, we integrated this expanded target dataset to predict effective drug combinations using our drug synergy prediction model DeepMDS. Experimental assay on breast cancer cell line MDA-MB-231 proved the efficacy of the best predicted multi-compound combinations: Combination I (Epicatechin, Ursolic acid, Quercetin, Aesculetin and Astragaloside IV) exhibited a half-maximal inhibitory concentration (IC50) value of 19.41 μM, and a combination index (CI) value of 0.682; and Combination II (Epicatechin, Ursolic acid, Quercetin, Vanillic acid and Astragaloside IV) displayed a IC50 value of 23.83 μM and a CI value of 0.805. These results validated the ability of our model to make accurate predictions for novel CPI data outside the training dataset and evaluated the reliability of the predictions, showing good applicability potential in drug discovery and in the elucidation of the bioactive compounds in TCM. Conclusion: Our CPI prediction model can serve as a useful tool for accurately identifying potential CPI for a wide range of proteins, and is expected to facilitate drug research, repurposing and support the understanding of TCM.

GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47

A general prediction model for compound-protein interactions based on deep learning

MCPI: Integrating Multimodal Data for Enhanced Prediction of Compound Protein Interactions

Compound–protein interaction prediction by deep learning: Databases, descriptors and models

A bidirectional interpretable compound-protein interaction prediction framework based on cross attention

DeepCPI: A Deep Learning-based Framework for Large-scale in Silico Drug Screening.

GraphCPIs: A novel graph-based computational model for potential compound-protein interactions

Prediction of protein–protein interactions based on elastic net and deep forest

DTI-CDF: a cascade deep forest model towards the prediction of drug-target interactions based on hybrid features

An end-to-end method for predicting compound-protein interactions based on simplified homogeneous graph convolutional network and pre-trained language model

MulinforCPI: enhancing precision of compound–protein interaction prediction through novel perspectives on multi-level information integration

Dowker complex based machine learning (DCML) models for protein-ligand binding affinity prediction

Boosting Compound-Protein Interaction Prediction by Deep Learning.

ParaCPI: A Parallel Graph Convolutional Network for Compound-Protein Interaction Prediction

In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences

Pred-binding: large-scale protein–ligand binding affinity prediction

In-silico Target Prediction by Ensemble Chemogenomic Model Based on Multi-Scale Information of Chemical Structures and Protein Sequences.

A uniﬁed framework for drug-target interaction prediction by semantic-guided meta-path method

Deep learning-driven prediction of drug mechanism of action from large-scale chemical-genetic interaction profiles

AlzhCPI: A Knowledge Base for Predicting Chemical-Protein Interactions Towards Alzheimer’s Disease

A new paradigm for applying deep learning to protein–ligand interaction prediction